Genital Diseases, Female  >>  apitolisib (GDC-0980)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
apitolisib (GDC-0980) / Roche
NCT01455493: A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
56
US
GDC-0980
Genentech, Inc.
Endometrial Carcinoma
03/13
01/14

Download Options